ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 68 filers reported holding ADC THERAPEUTICS SA in Q3 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269 | -58.3% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $645 | +10.3% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $585 | -49.2% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $1,152 | +15.2% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 300 | -14.3% | 0.00% | – |
| Q1 2022 | $5,000 | -50.0% | 350 | -30.0% | 0.00% | – |
| Q4 2021 | $10,000 | -28.6% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | -48.1% | 500 | -54.5% | 0.00% | – |
| Q2 2021 | $27,000 | -38.6% | 1,100 | -38.9% | 0.00% | – |
| Q1 2021 | $44,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $40,911,000 | 7.12% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $36,944,000 | 3.67% |
| Burrage Capital Management LLC | 124,875 | $3,041,000 | 3.05% |
| Redmile Group, LLC | 7,522,029 | $183,161,000 | 2.71% |
| Indie Asset Partners, LLC | 91,641 | $2,231,000 | 1.81% |
| MPM BioImpact LLC | 218,027 | $5,309,000 | 0.87% |
| Ikarian Capital, LLC | 300,000 | $7,305,000 | 0.59% |
| Eventide Asset Management | 1,311,990 | $31,948,000 | 0.43% |
| Virtus ETF Advisers LLC | 21,540 | $524,000 | 0.22% |
| AlphaCentric Advisors LLC | 26,000 | $633,000 | 0.17% |